I can sit through a biotech presentation and come away convinced that the company has discovered the

DENVER, Oct. 07, 2026 (GLOBE NEWSWIRE) -- ( www.247marketnews.com )-- For patients facing cancer, pr

DENVER, Oct. 06, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- A fall calendar is bringing NeOnc

DALLAS, Sept. 29, 2026 (GLOBE NEWSWIRE) -- (www.InvestorsTape.com) -- NeOnc Technologies Holdings (N

NeOnc (NASDAQ: NTHI) is scheduled to meet with the FDA for an in-person End-of-Phase 1 Type B meetin

The Company plans to seek FDA feedback on its NEO212 clinical development program, including an upda

CALABASAS, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTH

Roth Capital analyst Jonathan Aschoff initiates coverage on NeOnc Technologies Hldgs (NASDAQ:NTHI

DENVER, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NAS

DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com)– NeOnc Technologies Holdings (NASDAQ:

DENVER, Sept. 21, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – NeOnc Technologies Holdings' (NASDA

DENVER, Sept. 17, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies (NASDAQ: NTHI

CALABASAS, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTH

DENVER, Sept. 16, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NAS

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-

CALABASAS, Calif., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTH

NeOnc's (NASDAQ:NTHI) CEO purchased another 37,000 shares of the company's common stock, following a

DENVER, Sept. 14, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDA

DENVER, Sept. 09, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDA

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-

CALABASAS, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTH

DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – For NeOnc Technologies Holdings (NA

BTIG analyst Thomas Shrader reiterates NeOnc Technologies Hldgs (NASDAQ:NTHI) with a Buy and main

DENVER, Aug. 28, 2026 (GLOBE NEWSWIRE) -- For NeOnc Technologies Holdings (NASDAQ: NTHI), the most i

DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has reached a p

DENVER, Aug. 18, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ

Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular

Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular sess

— Study met its primary endpoint: six-month progression-free survival of 48.9% versus a pre-specifie

Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.58) per share which missed the ana

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinic

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a clini

NeOnc Technologies Holdings (NASDAQ:NTHI) is rapidly emerging as a development-stage neuro-oncology

Clearance enables Phase 2 evaluation of NEO212, the Company's oral perillyl alcohol-temozolomide

The transactions contemplated by the Purchase Agreement are expected to close upon the satisfaction

BTIG analyst Thomas Shrader reiterates NeOnc Technologies Hldgs (NASDAQ:NTHI) with a Buy and main

Alliance Global Partners analyst Matthew Venezia initiates coverage on NeOnc Technologies Hldgs (

Maxim Group analyst Jason McCarthy initiates coverage on NeOnc Technologies Hldgs (NASDAQ:NTHI) w

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.38) per share which missed the ana

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinic

Top Wall Street analysts changed outlook on top names. See analyst ratings page for complete view. W

BTIG analyst Thomas Shrader initiates coverage on NeOnc Technologies Hldgs (NASDAQ:NTHI) with a B

Entry into a Material Definitive Agreement. At The Market Offering On April 10, 2026, the Company en

 $300,000,000Common StockPreferred StockDebt SecuritiesWarrantsRightsUnitsFrom time to time, we may

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.72) per share which missed the ana

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-